Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
research and development
Biotech
NightHawk dives into CDMO, leaving R&D staffers in the lurch
NightHawk is officially dropping R&D and sending associated staff out the door to fully focus on its CDMO wing.
Annalee Armstrong
Sep 20, 2023 10:33am
The 10 highest value R&D projects in biopharma
Sep 5, 2023 6:00am
Oncology trial starts hit records as COVID disruptions ease
Jun 2, 2022 8:40am
Top 10 highest paid biopharma R&D executives in 2021
May 10, 2022 3:00am
Bayer's new R&D chief wants to push past Aspirin legacy
Jan 18, 2022 12:10pm
'What it takes': Genentech has 'never wavered' on Alzheimer's
Dec 1, 2021 7:00am